IGC Pharma
23 hedge funds and large institutions have $1.19M invested in IGC Pharma in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
8% less funds holding
Funds holding: 25 → 23 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
23
Holding in Top 10
–
Calls
$8K
Puts
$1K
Top Buyers
| 1 | +$56.8K | |
| 2 | +$41.9K | |
| 3 | +$33K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$27.9K |
| 5 |
Morgan Stanley
New York
|
+$7.21K |
Top Sellers
| 1 | -$66.1K | |
| 2 | -$9.57K | |
| 3 | -$302 | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$15 |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$3 |